SCHEMBL21684146

SCHEMBL21684146

C=C[C@H]1SC[C@@H]2OC(C)(C)O[C@@H]21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5364024 0.81 — —
SCHEMBL21683408 0.81 — —
SCHEMBL19129728 0.81 — —
SCHEMBL19124133 0.81 — —
SCHEMBL14296860 0.81 — —
SCHEMBL19145993 0.81 — —
SCHEMBL17752954 0.76 LSS (0.36) —
SCHEMBL15985093 0.76 LSS (0.36) —
SCHEMBL12561443 0.69 MGAM (0.31) —
SCHEMBL14477541 0.69 MGAM (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3833668-B1 PRMT5 INHIBITORS MERCK SHARP & DOHME LLC (US) 2025-03-19 — — EP disclosed
US-11993602-B2 PRMT5 inhibitors MERCK SHARP & DOHME LLC (US) 2024-05-28 — — US disclosed
US-20210277009-A1 PRMT5 INHIBITORS MERCK SHARP & DOHME CORP. (US) 2021-09-09 — — US disclosed
US-20210277009-A1 PRMT5 INHIBITORS MERCK SHARP & DOHME CORP. (US) 2021-09-09 — — US disclosed
EP-3833668-A1 PRMT5 INHIBITORS Merck Sharp & Dohme Corp. (US) 2021-06-16 — — EP disclosed
WO-2020033282-A1 PRMT5 INHIBITORS MERCK SHARP & DOHME CORP. (US) 2020-02-13 — — WO disclosed
Send feedback